297 related articles for article (PubMed ID: 23291940)
1. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.
Lazcano-Ponce E; Conde-Gonzalez C; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
Hum Vaccin Immunother; 2013 Feb; 9(2):375-81. PubMed ID: 23291940
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
Al-Aziz AM; Awad MA
East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074
[TBL] [Abstract][Full Text] [Related]
3. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization.
Zhu Y; Yuan Z; Zhao Q; Chen G; Xu B
Epidemiol Infect; 2013 Mar; 141(3):556-62. PubMed ID: 22687628
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 National Health and Nutrition Survey analysis.
López-Gatell H; García-García L; Echániz-Avilés G; Cruz-Hervert P; Olamendi-Portugal M; Castañeda-Desales D; Sanchez-Alemán MÁ; Romero-Martínez M; DeAntonio R; Cervantes-Apolinar MY; Cortes-Alcalá R; Alpuche-Aranda C
Vaccine; 2018 Dec; 36(52):8094-8099. PubMed ID: 30337174
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine.
Moisseeva AV; Marichev IL; Biloschitchkay NA; Pavlenko KI; Novik LV; Kovinko LV; Lyabis OI; Houillon G; Rasuli AM
J Viral Hepat; 2008 Oct; 15 Suppl 2():43-6. PubMed ID: 18837833
[TBL] [Abstract][Full Text] [Related]
7. Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil.
Vitral CL; Ospina FL; Artimos S; Melgaço JG; Cruz OG; de Paula VS; Luz SB; Freire M; Gaspar LP; Amado LA; Engstrom EM; Fortes CD; Souza TC; Dias MN; Gaspar AM; Souto FJ
Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):652-8. PubMed ID: 22850956
[TBL] [Abstract][Full Text] [Related]
8. [The seroprevalence rate, vaccination rate and seroconversion rate of hepatitis A in central region of Korea].
Yun SW; Lee WK; Cho SY; Moon SH; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Song IH; Lee KS; Lee JH
Korean J Gastroenterol; 2011 Mar; 57(3):166-72. PubMed ID: 21519164
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine.
Dhawan PS; Shah SS; Alvares JF; Kher A; Shankaran ; Kandoth PW; Sheth PN; Kamath H; Kamath A; Koppikar GV; Kalro RH
Indian J Gastroenterol; 1998 Jan; 17(1):16-8. PubMed ID: 9465507
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis A seroprevalence in public school children in Campos dos Goytacazes, Rio de Janeiro State, Brazil, prior to the introduction of the hepatitis A universal childhood vaccination.
Kury CM; Pinto MA; Silva JP; Cruz OG; Vitral CL
Cad Saude Publica; 2016 Nov; 32(11):e00175614. PubMed ID: 27982290
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis a in Lebanon: a changing epidemiological pattern.
Sacy RG; Haddad M; Baasiri G; Khoriati A; Gerbaka BJ; Abu-Elyazeed R
Am J Trop Med Hyg; 2005 Aug; 73(2):453-6. PubMed ID: 16103621
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
[TBL] [Abstract][Full Text] [Related]
13. Community-based cross-sectional seroprevalence study of hepatitis A in Bangladesh.
Saha SK; Saha S; Shakur S; Hanif M; Habib MA; Datta SK; Bock HL
World J Gastroenterol; 2009 Oct; 15(39):4932-7. PubMed ID: 19842225
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005-2015.
Haeri Mazanderani A; Motaze NV; McCarthy K; Suchard M; du Plessis NM
PLoS One; 2019; 14(6):e0216033. PubMed ID: 31242191
[TBL] [Abstract][Full Text] [Related]
15. Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico.
Carlos F; Gómez JA; Anaya P; Romano-Mazzotti L
Hum Vaccin Immunother; 2016; 12(1):52-63. PubMed ID: 26503702
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy.
John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P
J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469
[TBL] [Abstract][Full Text] [Related]
17. Modeling the hepatitis A epidemiological transition in Brazil and Mexico.
Van Effelterre T; Guignard A; Marano C; Rojas R; Jacobsen KH
Hum Vaccin Immunother; 2017 Aug; 13(8):1942-1951. PubMed ID: 28481680
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy.
Lee D; Cho YA; Park Y; Hwang JH; Kim JW; Kim NY; Lee DH; Lee W; Jeong SH
Intervirology; 2008; 51(2):70-4. PubMed ID: 18434743
[TBL] [Abstract][Full Text] [Related]
19. Evidence of hepatitis A virus circulation in central Argentina: seroprevalence and environmental surveillance.
Yanez LA; Lucero NS; Barril PA; Díaz Mdel P; Tenaglia MM; Spinsanti LI; Nates SV; Isa MB; Ré VE
J Clin Virol; 2014 Jan; 59(1):38-43. PubMed ID: 24332411
[TBL] [Abstract][Full Text] [Related]
20. Age-specific seroprevalence of hepatitis A in Antananarivo (Madagascar).
Raharimanga V; Carod JF; Ramarokoto CE; Chrétien JB; Rakotomanana F; Talarmin A; Richard V
BMC Infect Dis; 2008 Jun; 8():78. PubMed ID: 18538023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
